
Breakthrough British prostate cancer test could avoid need for biopsies in 80pc of men
A British-made prostate cancer test could avoid the need for biopsies in four out of five cases, according to a study. The EpiSwitch PSE next generation blood test uses advances in technology to identify prostate cancer, the most common form of the disease …